Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
McKinsey
Queensland Health
Federal Trade Commission
Medtronic
US Department of Justice
Boehringer Ingelheim
AstraZeneca
Healthtrust
QuintilesIMS

Generated: October 20, 2017

DrugPatentWatch Database Preview

Indapamide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for indapamide and what is the scope of indapamide patent protection?

Indapamide
is the generic ingredient in two branded drugs marketed by Amerigen Pharms Ltd, Mylan Pharms Inc, Actavis Elizabeth, Sanofi Aventis Us, Mylan, Teva, Watson Labs, Sandoz, and Ani Pharms Inc, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for indapamide. Ten suppliers are listed for this compound.

Summary for Generic Name: indapamide

US Patents:0
Tradenames:2
Applicants:9
NDAs:10
Drug Master File Entries: see list7
Suppliers / Packagers: see list10
Bulk Api Vendors: see list67
Clinical Trials: see list10
Patent Applications: see list4,633
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:indapamide at DailyMed

Pharmacology for Ingredient: indapamide

Drug ClassThiazide-like Diuretic
Physiological EffectIncreased Diuresis
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
INDAPAMIDE
indapamide
TABLET;ORAL074594-001May 23, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
INDAPAMIDE
indapamide
TABLET;ORAL074665-002Apr 4, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
LOZOL
indapamide
TABLET;ORAL018538-002Apr 29, 1993DISCNYesNo► Subscribe► Subscribe► Subscribe
Mylan
INDAPAMIDE
indapamide
TABLET;ORAL074461-001Mar 27, 1996ABRXNoYes► Subscribe► Subscribe► Subscribe
Amerigen Pharms Ltd
INDAPAMIDE
indapamide
TABLET;ORAL075201-001Dec 4, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
INDAPAMIDE
indapamide
TABLET;ORAL075105-002Jul 23, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
INDAPAMIDE
indapamide
TABLET;ORAL074461-002Mar 26, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms Inc
INDAPAMIDE
indapamide
TABLET;ORAL074498-001Oct 31, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
INDAPAMIDE
indapamide
TABLET;ORAL074585-002Sep 26, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms Inc
INDAPAMIDE
indapamide
TABLET;ORAL074498-002Feb 12, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: indapamide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us
LOZOL
indapamide
TABLET;ORAL018538-001Jul 6, 1983► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Covington
Julphar
Mallinckrodt
Deloitte
Medtronic
Accenture
McKinsey
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot